Furthermore, we also demonstrated that knockdown of circZFR could effectively prohibit cell proliferation and migration by targeting the miR-377/ZEB2 axis, suggesting a potential therapeutic target for circZFR in BC treatment. This evidence concerns the gene ZEB2 and breast cancer.